Duobrii in Combination With Biologics

StatusRecruiting
PhasePhase 4
Started

Record status This record was last updated April 30, 2020 (before its estimated August 1, 2020 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Oct 1, 2019 to Oct 14, 2019v2
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Trial Details
NCT Number NCT04119102
Lead Sponsor Psoriasis Treatment Center of Central New Jersey
Collaborators: Ortho Dermatologics
Conditions
(from sponsor)		 Psoriasis
Related terms Psoriasis
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov